Superworth

Movado price to free cash flow MOV

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026
9.8×
10-year median
11.3×
Against its 10-year history
35th
percentile: 0 is its lowest day, 100 its highest
10-year range
5.2× to 261×
Peer median
18.2×

Movado's price to free cash flow is 9.8× as of Oct 23, 2026.

That is below its ten-year median of 11.3×, lower than on 65% of days in the last ten years.

Over that time it ranged from 5.2× in Sep 2020 to 261× in Aug 2025.

The median for 10 medical instruments and supplies stocks of a similar size is 18.2×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far9.8×9.8×16.2×
202513.1×13.1×261×
202421.1×7.3×22.2×
20238.7×7.1×13.9×
202211.6×5.9×11.6×
20218.7×6.5×11.3×
20205.9×5.2×210×
2019215×9.1×216×
20188.9×8.5×19.6×
201713.7×8.6×13.7×
201613.9×7.8×15.3×
201510.0×8.7×26.2×
201425.8×17.4×39.8×
201339.8×16.5×70.5×
201214.7×11.2×17.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest Movado's size, closest first, today.

CompanyPrice to free cash flow
MOVMovado9.8×
MDXGMimedxn/m
TCMDTactile Systems Technology20.0×
IRMDIradimed43.7×
STAAStaar Surgicaln/m
BVSBioventus13.3×
CDRECadre16.4×
EMBCEmbecta2.3×
EYENational Vision30.1×
INFUInfuSystem12.1×
LMATLemaitre Vascular26.2×
Peer median18.2×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Movado

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.